Optiver Holding
NGNE icon

Optiver Holding’s Neurogene NGNE Stock Holding History

Optiver Holding’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35K Buy
67
+6
+10% +$116 ﹤0.01% 1992
2025
Q4 		$1.26K Sell
61
-15
-20% -$373 ﹤0.01% 2166
2025
Q3 		$1.32K Buy
+76
New +$1.53K ﹤0.01% 2469

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Optiver Holding's NGNE Position: Q1 2026 in Review

Optiver Holding increased its Neurogene (NGNE) stake by 9.8% in Q1 2026, buying an estimated $116 and bringing the position to 67 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1992.

Optiver Holding first reported a position in NGNE in Q3 2025 and has held it in 3 quarters since. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Optiver Holding held 67 shares of Neurogene worth $1.35K as of Q1 2026.
  • Optiver Holding bought 6 Neurogene shares in Q1 2026, an estimated $116.
  • Neurogene made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1992 holding.
  • Optiver Holding first reported a position in Neurogene in Q3 2025 and has held it in 3 quarters since.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.